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Abstract 
 
This paper describes the isolation, purification and characterization of a potential Angiotensin-
Converting Enzyme (ACE) inhibitory peptide from the leaves of Leptadenia hastata (Asclepiadaceae). 
The leaves were collected from Kano state, Nigeria. Crude proteins were extracted from the leaves 
using a protein extraction kit. The proteins were purified by a three-step method: cold acetone 
precipitation, gel filtration using chromatography sephadex G-100 and ion exchange chromatography 
using CM-sephadex. The ACE inhibitory activity, protein content, effect of pH, temperature and 
digestive enzymes on the activity of the isolated and purified peptide were determined. In addition, the 
inhibition pattern, amino acid composition and sequence of the purified peptide were investigated. The 
specific inhibitory activity of the peptide increased from 0.0018 to 0.0085 U.mg-1 at a purification fold 
of 4.72 and yield of 9.57%. The optimum temperature and pH of the peptide ACE inhibitory activity 
was found to be 40ºC and 7.0 respectively. The digestive enzymes, pepsin and trypsin significantly 
(P<0.05) reduced the activity of the peptide compared to antihypertensive drug enalapril. The amino 
acid composition of the peptide was found to be aspartate (Asp), glutamate (Glu), glycine (Gly), valine 
(Val), leucine (Leu) and phenylalanine (Phe). The purified peptide showed a mixed pattern type of 
ACE inhibition. In conclusion, the results of this work suggest that Leptadenia hastata 
(Asclepiadaceae) leaves could be a potential source of peptides with high ACE inhibitory activities. 
 
Keywords: Leptadenia hastata (Asclepiadaceae); angiotensin converting enzyme; hypertension; 
peptide. 
 
 
Introduction 
 
Angiotensin converting enzyme (ACE, dipeptidyl carboxypeptidase I, kinase II, EC. 3.4.15.1) 
is a multifunctional zinc metallopeptidase found in various tissues (Ondetti and Cushman, 
1982). ACE has four functional amino acid residues (tyrosine, Tyr; arginine, Arg; glutamate, 
Glu and lysine, Lys) at the active site, and three hydrophobic binding sub-sites. It plays an 
important role in the regulation of blood pressure via the renin-angiotensin system (RAS) and 
kallikrein-kinin system (KKS) (Li et al., 2004). RAS plays crucial role in the blood pressure 
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regulation and in the pathophysiology of cardiovascular diseases. Within the RAS, 
angiotensin is converted by plasma renin into angiotensin I (decapeptide), which undergoes 
proteolytic cleavage in the presence of ACE, to form angiotensin II (octapeptide), a potent 
vasoconstrictor. Angiotensin II raises blood pressure by acting directly on blood vessels, 
sympathetic nerves and adrenal glands (Matsui et al., 2000). In addition, ACE degrades 
bradykinin, which has vasodilatation properties in KKS (Li et al., 2004). Thus, to prevent the 
pathogenesis of hypertension, production of angiotensin II has to be suppressed via 
inhibition of ACE activity. Several ACE inhibitors, such as captopril, enalapril, and lisinopril 
used as antihypertensive drugs in clinical practice possess adverse effects (Vercruysse and 
Smagghe, 2005). Hence, the need for search and development of safe and natural ACE 
inhibitors from dietary sources. 
Adequate evidence from epidemiological and laboratory studies link several nutrients, 
minerals, food groups and dietary patterns with a decreased risk of hypertension (Reddy and 
Katan, 2004). In recent years, food-derived ACE inhibitory peptides have been extensively 
studied as an alternative for prevention or management of high blood pressure. The 
occurrence of ACE inhibitors in maize, sunflower, wheat germ, mushrooms, and lentils has 
been reported. Also, food protein sources such as soybean, egg, milk and fish have been 
found to be rich sources of ACE inhibitory peptides (Chia-Ling et al., 2012). Indigenous 
plants, such as Moringa oleifera also contain ACE inhibitory peptides (Abdulazeez et al., 
2015a).  
Leptadenia hastata belongs to the Asclepiadaceae family. It is wild, edible non-
domesticated vegetable found throughout Africa. It is used as food and for the treatment of 
various ailments (Aliero et al., 2001; Barbana and Boye, 2011). The plant is commonly used 
in the Hausa speaking communities in Nigeria as a spice (Ibrahim et al., 2012), for the 
treatment of hypertension, catarrh and skin diseases (Dambatta and Aliyu, 2011). In 
Senegal, the leaves are used for to improve lactation and as a purgative (Arbonnier, 2000; 
Kerarho and Adam, 1974). The antimicrobial effects of L. hastata have been reported (Aliero 
et al., 2001) and the result of its toxicity studies showed that the plant is relatively safe 
(Tamboura et al., 2005). However, there is paucity of information on its ACE inhibitory 
activity, hence this study aims to isolate and characterize ACE inhibitory peptide from L. 
hastata, determine the amino acid composition, and investigate its inhibition pattern.  
 
 
Materials and Methods 
 
Chemicals and Reagents  
 
Angiotensin Converting Enzyme Inhibition Screening Kit (Kamiya Biomedical Company, 
Seattle, U.S.A), Pepsin (porcine stomach mucosa) and trypsin were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA), sodium chloride, sodium monophosphate, sodium 
diphosphate, hydrochloric acid, sodium hydroxide, acetone, Bradford reagent, Bovine Serum 
Albumin, potassium diphosphate and all other reagents used in the study are of analytical 
grade. 
 
 
Collection and Identification of Plant Sample  
 
Fresh leaves of L. hastate (Asclepiadaceae) were collected from Rijiyar Zaki, Gwale Local 
Government Area, Kano state, Nigeria. The plant was authenticated at the herbarium of the 
Department of Botany, Bayero University, Kano with a voucher number BUKHAN 0248. 
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Purification of ACE Inhibitory Proteins from Leptadenia hastata 
 
Isolation of Crude Protein 
 
Fresh leaves of Leptadenia hastata were washed under running tap water until clean and 
crude protein was isolated using protein extraction kit (Minute TM Total Protein Extraction Kit 
for Plant Tissues, Invent Biotechnologies, Inc., USA). Briefly, 50-100 mg fresh leaves of L. 
hastata was placed in the protein extraction filter cartridge that had been pre-chilled in 
collection tube on ice, by folding and rolling into smaller volume. About 50 - 100 µL buffer 
was added to the filter and the leaves ground using a plastic rod for 3 minutes with twisting 
force. The filter was capped and incubated at room temperature for 1 - 2 minutes, then 
centrifuged at 3000 rpm for 5 minutes. The protein extract was collected as supernatant into 
a fresh test tube. This process was repeated using new protein extraction cartridges to obtain 
enough protein extract.  
 
Protein Precipitation  
 
Protein extracted (supernatants) obtained from leaves of L. hastata were precipitated using 
cold acetone at a ratio of 1:4. The precipitated proteins were vortexed and incubated at -
20°C for 60 minutes and then centrifuged for 10 minutes at 4°C and 3000 rpm. Acetone was 
allowed to evaporate from the uncapped test-tube. The pellet was reconstituted in 5 mL 
phosphate buffer (pH 7.4) to determine the ACE inhibitory activity and protein content. 
 
Dialysis 
 
A 10,000 Da membrane was prepared and loaded with 50 mL of the extracted protein, 
placed in a container containing 200 ml of phosphate buffer (pH 8.4), and dialyzed at 4ºC for 
2 hours. The buffer was changed and volume increased to 500 mL. This was left to dialyze 
for another 28 hours. 
 
Gel Filtration Using Sephadex G-100 
 
The precipitated protein was dissolved in phosphate buffer and subjected to gel filtration 
chromatography. The gel was soaked overnight in phosphate buffer (pH 7.8). The column 
was packed with the gel and washed with the same buffer. The protein was poured into the 
column and allowed to elute at a flow rate of 0.5 mL.min-1. Twelve (12) fractions of the 
sample were collected, 5 mL each. The protein content and ACE inhibitory activity of each 
fraction was determined and fractions that showed high ACE inhibitory activity were further 
purified by ion exchange chromatography. 
 
Ion Exchange Chromatography 
 
The fractions with strong ACE inhibitory activities obtained after gel filtration was pulled 
together and loaded onto a CM-Sephadex column which was pre-equilibrated with 
phosphate buffer solution (pH 7.8), then eluted at a linear gradient of NaCl (0.1 - 0.5 M) in 
the same buffer. Protein content and ACE inhibitory activity of the eluents were assayed. 
 
Determination of ACE Inhibitory Activity  
 
This was done using the K - Assay ACE inhibition screening kit, Kamiya Biomedical 
Company, USA, which utilizes 3-hydroxybutyl gly-gly-gly (3HB-GGG) as a substrate for ACE, 
and the amount of cleaved 3-hydroxybutyric acid (3HB) from 3HB-GGG measured by an 
enzymatic method. Briefly, 20 µL each of the samples, substrate and enzyme solution was 
added to a sample well, while 20 µL each of deionized water, substrate and enzyme solution 
added to another well (blank 1). For blank 2, 40 µL of deionized water and 20 µL of substrate 
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were added. The plate was incubated at 37ºC for 60 minutes, before adding 200 µL of 
indicator working solution to each well. This was further incubated for 10 minutes. The 
absorbance was read at 450 nm with a microplate reader. 
 
ACE inhibitory activity (inhibition rate %)     =     
 
 2blank1blank
sample1blank
AA
100AA


  
 
Inhibition was expressed as the concentration of inhibitor that inhibits 50% of ACE activity 
(lC50), and was calculated using a non-linear regression from a plot of activity versus 
inhibitory concentration of at least five separate determinations. Each assay was performed 
in triplicate. 
 
Determination of Protein Content 
 
The protein concentration of all fractions collected was determined by Bradford method using 
Serum Bovine Albumin (BSA) as standard and the concentration was expressed in milligram 
per milliliter. 
 
 
Characterization of ACE Inhibitory Peptide from Leaves of L. hastata 
 
Effect of Temperature on ACE Inhibitory Activity 
 
The extracted peptide was dissolved in milli - Q water and subsequently incubated with ACE. 
The effect of temperature on the activity of the purified peptide was analyzed after incubation 
at 20, 30, 40, 50, 60 and 70°C for 1 h. 
 
Effect of pH on ACE Inhibitory Activity 
 
The effect of pH on the peptide was determined by varying the pH of reaction mixture from 3 
to 10, and the ACE inhibitory activity determined at the different pH. 
 
Effect of some Metal Ions on ACE Inhibitory Activity  
 
ACE inhibitory activity was determined (method described in the previous section on 
Determination of ACE Inhibitory Activity) in the presence of the monovalent and divalent 
metal ions in their chloride forms; Sodium, Potassium, Magnesium, Calcium as well as 
EDTA; each at a concentration of 2 mM. 
 
Effect of Digestive Enzymes on ACE Inhibitory Activity 
 
The stability of ACE inhibitory peptide against some digestive enzymes was assessed in 
vitro. The purified peptide solution was successively digested with pepsin and trypsin as 
previously described and the digests were performed for the determination of ACE inhibitory 
activity. 
 
Determination of the Inhibition Pattern of the Peptide. 
 
The substrate (3HB-GGG) at various concentrations (0 to 5 mM) was incubated with the ACE 
solution in the absence and presence of 0.5, 1.0 mg/mL of inhibitor solution (purified 
peptides) at 37°C, and each reaction mixture assayed for ACE inhibition. The kinetic 
constants (Km and Vmax) values for the reaction at different concentrations of purified peptides 
were calculated using the Line weaver-Burk plots. 
Determination of Amino Acid Composition  
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The amino acid profile of the peptide was determined using methods described by Benitez 
(1989). The sample was dried to constant weight, hydrolyzed and evaporated in a rotary 
evaporator before loading into the Technicon sequential Multi-Sample Amino Acid Analyzer 
(TSM), Technicon Industrial Systems, USA. 
 
 
Results 
 
Purification of Leaves of L. hastata 
 
Table 1. summarises the purification steps used in the isolation of proteins from the leaves of 
L. hastata. The results showed that both the crude proteins obtained from the leaves and the 
purified peptide after acetone precipitation, gel filtration and ion exchange chromatography 
possess ACE inhibitory activity. The total protein content obtained decreased from 52.86 mg 
of crude to 1.05 mg after ion exchange chromatography. The inhibitory activity of the crude 
protein was estimated to be 0.0940 U with a specific inhibitory activity of 0.0018 U.mg-1. 
After undergoing acetone precipitation, gel filtration and ion exchange chromatography, the 
specific inhibitory activity increased to 0.0085 U.mg-1 at a purification fold of 4.72 and a 
percentage yield of 9.57 (Table 1). 
 
 
Table 1. Purification table of the purified ACE inhibitory peptide from L. hastata leaves 
   
Purification step Protein 
content 
(mg/mL) 
Total 
protein 
(mg) 
Inhibitory 
activity 
(µmol/min) 
Specific 
inhibitory activity 
(µmol/min/mg) 
Purification 
fold 
Yield 
% 
Crude  1.762 52.86 0.0940 0.0018 1.00 100 
 
Acetone 
Precipitation  
 
1.532 22.98 0.0521 0.0023 1.260 55.43 
Gel filtration 1.394 6.97 0.0245 0.0035 1.953 26.06 
 
Ion exchange 
Chromatography 
0.175 1.05 0.0090 0.0085 4.722 9.57 
 
 
The percentage ACE inhibition (Fig. 1) increased from fraction 1 to 3, decreased sharply 
from fraction 3 to 4 and then increased from fraction 4 to 5. The percentage ACE inhibition of 
the proteins decreased gradually from fraction 9 to 12. Fractions 3, 5, and 9 having higher 
ACE inhibitory activity and a proportionate protein concentration were then pulled together 
for ion exchange chromatography. Each fraction from ion exchange chromatography was 
collected for each gradient (0.1 to 0.5M NaCl) eluted (Fig. 2). Fraction 1 (0.1M NaCl) having 
the highest ACE inhibitory activity of 78% was then characterized. 
 
 
Effect of pH and Temperature on Purified Peptide from L. hastata Leaves 
 
The inhibitory activity of the purified peptide on ACE was optimal at pH 7.0, with the activity 
decreasing as the pH tends to 10 (Fig. 3), while the activity increase with increase in 
temperature until a peak was obtained at 40oC, after which further increase in temperature 
caused a decrease in inhibitory activity (Fig. 4). 
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Figure 1.  Elution profile of the purified ACE inhibitory peptide from sephadex G-100 gel filtration 
chromatography 
 
 
 
 
 
 
 
Figure 2. Elution profile of the purified ACE inhibitory peptide after ion exchange chromatography 
using CM-sephadex 
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Figure 3. Effect of pH on the activity of purified peptide obtained from the leaves of L hastata 
 
 
 
 
 
Figure 4. Effect of temperature on the activity of purified peptide obtained from the leaves of L. 
hastata 
 
 
Effect of Digestive Enzymes on the Purified Peptide from L. hastata Leaves 
 
The ACE inhibitory activities of the purified peptide from the leaves of L. hastata were 
expressed based on the inhibition percentage values. From the results, the activity of the 
peptide decreased significantly (P<0.05) when treated with gastrointestinal enzymes, pepsin 
and trypsin compared to the standard antihypertensive drug, enalapril (93 ± 2.5 U.ml-1) and 
untreated peptide (Fig. 5). The percentage inhibition of the untreated peptide obtained from 
the leaves (80 ± 1.3 %) decreased significantly (P<0.05) when treated with pepsin (75 ± 2.18 
%) and trypsin (43 ± 2.34 %) (Fig. 5). 
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Figure 5. Effect of digestive enzymes on the purified peptide obtained from the leaves of L. hastata 
 
 
Amino Acid Composition of the Purified Peptide from L. hastata Leaves 
 
The crude protein contained seventeen amino acids, with Glutamic acid concentration (10.59 
g/100g protein) being the highest, followed by Aspartic acid (7.95 g/100g protein), while 
Cysteine (0.69 g/100g protein) was lowest (Table 2). On the other hand, the purified peptide 
recovered was a hexapeptide containing six amino acids Asp, Glu, Gly, Val, Leu, Phe. And 
just as in the crude protein, Glutamic acid was present in the highest concentration 
(1.21g/100g), followed by aspartic acid with 0.79g/100g protein (Table 3). The peptide had 
an aspartic acid at the N terminal end and phenylalanine at the C terminal end. 
 
 
Table 2. Amino acid analysis of crude protein obtained from L. hastata leaves 
 
Amino Acid Protein Concentration (g/100g protein) 
Lysine 3.79 
Histidine 2.16 
Arginine 4.76 
Aspartic acid 7.95 
Threonine 2.98 
Serine 2.99 
Glutamic acid 10.59 
Proline 2.08 
Glycine 3.35 
Alanine 3.97 
Cystine 0.69 
Valine 4.25 
Methionine 0.86 
Isoleucine 3.06 
Leucine 6.69 
Tyrosine 2.85 
Phenylalanine 3.78 
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Table 3. Amino acid analysis of the purified peptide obtained from the leaves of L. hastate 
 
Amino Acid Concentration (g/100 g protein) 
Aspartic acid 0.79 
Glutamic acid 1.21 
Glycine 0.46 
Valine 0.54 
Leucine 0.55 
Phenylalanine 0.35 
 
 
Determination of Inhibitory Pattern of Purified Peptide from L. hastata Leaves 
 
The ACE inhibition pattern of the purified peptide showed a mixed type of inhibition, with a 
decrease in Vmax and an increase in Km as concentration of inhibitor increased. The Vmax of 
the peptide decreased from 0. 04U.ml-1 (no inhibitor) to 0.034 U.ml-1 (0.5 mg.ml-1 inhibitor) 
and finally 0.03 U.ml-1(1.0 mg.ml-1 inhibitor). On the other hand, the Km value increased from 
3.3 mM (no inhibitor) to 4.1 mM and 6.3mM at 0.5 mg.ml-1and 1.0 mg.ml-1of the inhibitor 
respectively (Fig. 6). 
 
 
 
 
Figure 6. Lineweaver-Burk’s plot for the inhibition of angiotensin converting enzyme by the purified 
peptide from the leaves of Leptadenia hastata 
 
 
Discussion 
 
In Nigeria and most African countries, herbs have been used as constituents of traditional 
medicines because they are relatively inexpensive, easily available with few adverse effects 
(Bako et al., 2005). Many antihypertensive ACE inhibitors have been isolated from natural 
sources, including algae protein waste (Sheih et al., 2009), oyster (Jiapei et al., 2008) and 
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buckwheat (Min-Suk et al., 2006). These inhibitors have also been isolated from Moringa 
oleifera (Abdulazeez et al., 2015a; Abdulazeez et al., 2016) and Peristrophebi calyculata 
(Abdulazeez et al., 2015b) herbs used in the treatment of hypertension in Nigeria. In the 
present study, preliminary evaluation revealed that the peptide obtained from L. hastata 
actively inhibited ACE in vitro with an IC50 value of 0.0090 ± 0.0007 U/mL. This is lower than 
that of peptides from Hibiscus rosasinensis (0.43 ± 0.04 U/mL) and Vinica leaves (1.37±0.06 
U/mL) (Aprilita et al., 2013), and may be attributed to differences in assay conditions 
substrate used and source of ACE. 
The removal of components capable of interacting with the peptide, and thus affecting 
its activity; during purification via acetone precipitation, gel filtration and ion exchange 
chromatography may have increased the specific activity from 0.0940 to 0.0090 U/mg (Table 
1). This conforms to studies by Sallau et al. (2008), who attributed the increase in activity of 
proteins during purification to the removal of other synergistically interacting components of 
the protein. The percentage yield of the purified peptide (9.57%) was low, though the 
purification folds increased, suggesting that the modified purification steps may increase 
peptide yield (Sallau et al., 2008). 
The isolated peptide exhibited optimal ACE inhibitory activity at pH 7.0, showing that 
acidic or alkaline conditions away from neutrality may affect it. The optimal temperature of 
the peptide was found to be 40ºC hence, higher and lower temperatures affect its activity, 
possibly due to thermal denaturation at high temperatures (Qu et al., 2010). Hence, the 
peptide may be regarded as unstable even though, it still possessed some degree of activity 
(>10%) at temperatures between 20 and 70°C and pH 5 and 9. The optimum temperature 
(40ºC) conforms to that of ACE inhibitors obtained from M. oleifera (Abdulazeez et al., 
2015a), but higher than that of P. adiposa (30ºC) (Koo et al., 2006) and lower than P. 
cornucopiae (50ºC) (Jang et al., 2011). This peptide is unlike ACE inhibitors obtained from 
Porphyra yezoensis (Qu et al., 2010) and algae protein waste (Sheih et al., 2009) found to be 
stable at different temperatures and pH, it is therefore important to investigate its effect under 
gastrointestinal conditions. 
In order to produce antihypertensive activity in vivo, peptides must be absorbed intact 
through the intestine and reach the target organ (Wilson et al., 2011). The in vitro 
gastrointestinal enzyme incubation provides an easy process to imitate the fate of peptides 
after oral administration, because some ACE inhibitors may fail to show their hypotensive 
activity after oral administration in vivo, due to the possible hydrolysis of these peptides by 
ACE or gastrointestinal proteases (Fujita et al., 2000; Li et al., 2004). To evaluate the stability 
of the purified peptide under gastrointestinal enzymes digestion, the purified peptide was first 
incubated with two gastrointestinal enzymes; pepsin and trypsin, and then subjected to ACE 
inhibitory activity assays. The results showed an apparent change after in vitro incubation 
with gastrointestinal enzymes (p > 0.05), suggesting little resistance of the peptide to 
digestion in the gastrointestinal tract, and that the active sequence of the peptide may be 
affected by these enzymes., but it remained active. This report agrees with studies by Choi et 
al. (2001) who reported that a decrease in ACE activity after treatment with gastrointestinal 
enzymes does not mean they may be ineffective after oral administration because they still 
maintained their inhibitory activity. Also, Fujita and Yoshikawa (1999) demonstrated that 
degradation of ACE inhibitory peptides by gastrointestinal enzymes might not affect the 
hypotensive activity as several ACE inhibitory peptides with weak in vitro activity produce a 
strong antihypertensive effect in vivo. They attributed this to the fact that in vivo activity also 
depends on other factors such as routine of administration, food matrix and intestinal 
absorption. Therefore, purified peptide obtained from the leaves of L. hastata may still be 
effective in reducing blood pressure. 
The difference observed from the number and types of amino acids found in the crude 
protein compared to that in the purified peptide might be attributed to the purification steps 
(Table 2 and 3). The purified peptide contained the following amino acids: Asp, Glu, Gly, Val, 
Leu, Phe. Though most of the reported peptides exhibiting ACE inhibitory activity contained 
5-13 amino acids (Li et al., 2004), many more ACE inhibitory proteins contained less than 
five, e.g. those obtained from human plasma (Nakagomi et al., 2000), and fermented 
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soybean food (Kuba et al., 2003). Other proteins include that from Limanda aspera frame 
(Jung et al., 2006) and human serum albumin (Nakagomi et al., 2000).  
Studies have demonstrated that most reported peptides are competitive inhibitors 
against ACE, and a few inhibit ACE in a non-competitive manner (Li et al., 2004). From the 
Lineweaver-Burks’ plot (Fig. 6), the inhibition pattern of the purified peptide from L. hastata 
showed a mixed type of inhibition. This means that the inhibitor binds to the enzyme at a 
different site away from the enzymes active site or it binds to the enzyme-substrate complex, 
thereby inhibiting the enzyme by causing a conformational change, which prevents the 
enzyme from converting substrate to product. The Vmax decreased and Km may either be 
increased or decreased. ACE inhibitors isolated from Grifola frondosa (Choi et al., 2001), T. 
giganteum (Lee et al., 2004) and Peristrophe bicalyculata (Abdulazeez et al., 2013) were 
reported to exhibit a competitive pattern of inhibition, while those isolated from algae protein 
waste (Sheih et al., 2009) and lentils (Burkill, 1985) were found to be non-competitive 
inhibitors.  
 
 
Conclusion 
 
In conclusion, this study has established the potential antihypertensive health benefit of a 
novel peptide from Leptadania hastata, and thus its potential for use as functional food 
component. This also explains its traditional use in the treatment of hypertension.. 
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